Infections and vaccines in the etiology of antiphospholipid syndrome
Purpose of review: To present scientific evidence supporting the infectious origin for the antiphospholipid syndrome (APS) by molecular mimicry between pathogens, infection and vaccination with ?2-glycoprotein I (?2-GPI) molecule. Recent findings: APS is characterized by the presence of pathogenic a...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2012
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/23823
- Acceso en línea:
- https://doi.org/10.1097/BOR.0b013e32835448b8
https://repository.urosario.edu.co/handle/10336/23823
- Palabra clave:
- 4 aminobutyric acid
Aluminum hydroxide
Beta2 glycoprotein 1
Beta2 glycoprotein 1 antibody
Cardiolipin antibody
Diphtheria antibody
Ganglioside antibody
Glycerol
Immunoglobulin a antibody
Immunoglobulin g antibody
Immunoglobulin m antibody
Interleukin 1 receptor
Laminin
Myeloid differentiation factor 88
Tetanus toxoid
Toll like receptor
Antibody production
Antiphospholipid syndrome
Autoinflammatory disease
Blood clotting time
Clostridium tetani
Cross reaction
Enzyme linked immunosorbent assay
Fetus wastage
Human
Infection
Medical history
Molecular mimicry
Nonhuman
Partial thromboplastin time
Priority journal
Review
Signal transduction
Tetanus prophylaxis
Thrombocytopenia
Antiphospholipid syndrome
Autoantibodies
Beta 2-glycoprotein i
Cross reactions
Humans
Infection
Molecular mimicry
Tetanus toxoid
?2-glycoprotein i
Antiphospholipid syndrome
Tetanus toxoid
immunologic
Adjuvants
- Rights
- License
- Abierto (Texto Completo)
Summary: | Purpose of review: To present scientific evidence supporting the infectious origin for the antiphospholipid syndrome (APS) by molecular mimicry between pathogens, infection and vaccination with ?2-glycoprotein I (?2-GPI) molecule. Recent findings: APS is characterized by the presence of pathogenic autoantibodies against ?2-GPI. The infection etiology of APS was well established. Likewise, a link between vaccination such as tetanus toxoid may trigger antibodies targeting tetanus toxoid and ?2-GPI, due to molecular mimicry between the two molecules. During the years, the pathogenic potential of anti-tetanus toxoid antibodies cross reactive with ?2-GPI were found to be pathogenic in animal models, inducing experimental APS. Summary: Accumulated evidence supports that the presence of anti-?2-GPI antibodies is associated with a history of infections and the main mechanism to explain this correlation is molecular mimicry. The relationship between tetanus toxoid vaccination and APS reveals a novel view on the autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA). © 2012 Wolters Kluwer Health |
---|